Cited by 31Ovarian cancer diagnosis and treatmentEndometriosis Research and TreatmentEndometrial and Cervical Cancer Treatments

Clinical characteristics of patients in Japan with ovarian cancer presumably arising from ovarian endometrioma

Taniguchi, Fuminori, Harada, Tasuku, Kobayashi, Hiroshi, Hayashi, Kunihiko, Momoeda, Mikio, Terakawa, Naoki·2014·Gynecologic and Obstetric Investigation

Abstract

OBJECTIVE: To investigate the clinical features of patients in Japan with malignant transformation of ovarian endometrioma. PATIENTS: Thirty-three patients diagnosed with ovarian cancer presumably arising from endometrioma were recruited retrospectively. These patients had been followed for at least 2 years after the ovarian endometrioma diagnosis, then continued to be followed after they had been found to have malignant transformation. RESULTS: The average age of the patients was 47.7 ± 9.3 years; 75.7% were premenopausal at the time of diagnosis of ovarian cancer. Among the 33 patients, ovarian cancer developed in the ipsilateral ovary of 6 patients with endometrioma after cystectomy. Twenty-eight patients were diagnosed with stage I ovarian cancer, and major histotypes were clear cell in 23 cases and endometrioid in 8. Before surgery for cancer, mural nodules within the endometriomas were detected in 32 patients, and 1 patient had a small 3-mm nodule. In 30 patients, the diameter of the tumor doubled in size 6 months prior to the diagnosis of malignant transformation. The diameter of the endometrioma and the preoperative CA125 value did not significantly correlate. CONCLUSIONS: To detect malignant transformation of ovarian endometrioma early and precisely, the clinician should determine the existence of a mural nodule and assess the rapid growth of the endometrioma.

Integrity signals

Registry

Crossref · 10.1159/000357819

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Taniguchi, F., Harada, T., Kobayashi, H., Hayashi, K., Momoeda, M., & Terakawa, N.
Affiliations
  • Tottori University (JP)
  • Nara Medical University (JP)
  • Gunma University (JP)
  • St. Luke's International Hospital (JP)
Venue
Gynecologic and Obstetric Investigation
Publisher
S. Karger AG
Published
2014
Volume
77
Issue
2
Pages
104-110
ISSN
  • 0378-7346 (ISSN-L)
  • 1423-002X
OpenAlex
W2020045892
Cited by
31
References
23
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 2 · 2021: 1 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 3 · 2015: 3
FWCI
3.64
Type
journal article
Language
en
Open access
closed
Locations
  • Gynecologic and Obstetric Investigation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords
endometrioma, malignant transformation, ovarian cancer, clear cell carcinoma, endometrioid carcinoma, mural nodules, tumor growth rate, CA125, cystectomy, premenopausal women, early detection
MeSH terms
Adult, Aged, Cell Transformation, Neoplastic, Endometriosis, Female, Follow-Up Studies, Humans, Japan, Magnetic Resonance Imaging, Membrane Proteins, Middle Aged, Neoplasm Staging, Ovarian Cysts, Ovarian Neoplasms, Retrospective Studies, Ultrasonography, Adenocarcinoma, Clear Cell, Carcinoma, Endometrioid, CA-125 Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review